Influence of the body mass and visceral adiposity on glucose metabolism in obese women with Pro12Pro genotype in PPARgamma2 gene;Influencia de la masa corporal y de la adiposidad visceral en el metabolismo de la glucosa en mujeres obesas con el genotipo Pro12Pro en el gene PPARgamma2

Nutricion Hospitalaria

Volumn 28, Issue 3, 2013, Pages 694-700

  Chaia Kaippert, Vanessa ^a   Kimi Uehara, Sofia ^a   Lima, Carla D'Andrea ^a   Nogueira, Juliana ^a   do Lago, Márcia Fófano ^a   dos Santos Lopes, Marcelly Cunha Oliveira ^a   Morais Oliveira, Edna Maria ^b   Lopes Rosado, Eliane ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b EMBRAPA CERRADOS   (Brazil)

Author keywords

Body mass index; Glucose metabolism; Insulin resistance; Obesity; PPARgamma

Indexed keywords

GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; MORBID OBESITY; YOUNG ADULT;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GLUCOSE; HUMANS; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY, MORBID; PPAR GAMMA; YOUNG ADULT;

EID: 84876941649     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.3.6372     Document Type: Article

References (36)

1. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica: Diretrizes Brasileiras de Obesidade. 2007.
2. Froguel P, Boutin P. Genetics of pathways regulating body weight in the development of obesity in humans. Exp Biol Med 2001; 226 (11): 991-6.
3. Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: The role of PPARg gene polymorphisms. Physiol Behav 2006; 88: 227-33.
4. Farooqi IS, O'rahilly S. Genetic factors in human obesity. Obes Rev 2007; 8 (Suppl. 1): 37-40.
5. Grommes C, Landreth GE, Heneka MT. Antineoplastic effects of peroxisome proliferator-activated receptor ffagonists. Lancet Oncol 2004; 5: 419-29.
6. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B et al. Regulation of PPARg gene expression by nutrition and obesity in rodents. J Clin Invest 1996; 97: 2553-61.
7. Kanunfre CA. PPAR-Receptor ativado por proliferadores de peroxissoma um receptor nuclear para ácidos graxos, In: Curi R, Pompéia C, Miyasaka CK, Procópio J. Entendendo a gordura-os ácidos graxos. São Paulo: Manole, pp. 227-48, 2002.
8. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor g. Obes Res 2002; 10 (6): 518-25.
9. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J et al. Pro12Ala substitution in PPARK2 associated with decrease receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-7.
10. Abranches MV, Oliveira FCE, and Bressan J. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus. Nutr Hosp 2011; 26 (2): 271-9.
11. Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA et al. The common PPAR-g2 Pro12Ala variant is associated with greater insulin sensitivity. Eur J Hum Genet 2004; 12: 1050-4.
12. Robitaille J, Després J-P, Pérusse L, Vohl M-C. The PPARgamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study. Clin Genet 2003; 63: 109-16.
13. Anaya COM, Ariza IDS. Avances en obesidad. Rev Fac Med Univ Nac Colomb 2004; 52 (4): 270-86.
14. Carpentier YA, Portois L, Malaisse WJ. n-3 Fatty acids and the metabolic syndrome. Am J Clin Nutr 2006; 83 (Suppl): 1499S-1504S.
15. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'homme D, Lupien PJ et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-34.
16. World Health Organization (WHO): Obesity: prevention and managing the global epidemic. In: Report of the WHO Consultation on Obesity. Geneva: World Health Organization; 1998.
17. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Santos RD. III Diretrizes Brasileiras sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001; 77 (Supl. III): 1-48.
19. American Diabetes Association (ADA): Diagnosis and classification of Diabetes Mellitus. Diabetes Care 2007; 30 (Suppl. I): S42-S47.
20. Sánchez-Margalet V, Valle M, Ruz FJ, Gascón F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002; 13: 75-9.
21. Matthews DR, Hosker JP, Rudenski BA, Naylor DF, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
22. Geloneze B, Geloneze SR, Ermetice MN, Repetto EM, Tambascia MA. The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pract 2006; 72 (2): 219-20.
23. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85 (7): 2402-10.
24. Bonneau GA, Rascon CMS, Pedrozo WR, Ceballos B, Leiva R, Blanco N et al. Presencia de insulinorresistencia en Síndrome metabólico. Rev Argent Endocrinol Metab 2006; 43: 215-23.
25. World Health Organization (WHO): Physical Status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995; 854: 1-452.
26. Rosado EL, Bressan J, Hernández JAM, Martins MF, Cecon PR. Efecto de la dieta y de los genes PPARg2 y P2-adrenérgico en el metabolismo energético y en la composición corporal de mujeres obesas. Nutr Hosp 2006; 21 (3): 317-31.
27. Gen Bank DNA: AB005520. Homo sapiens ppar [gi:2605488]. www.ncbi.nlm.nih.gov/genbank. Accessed Jan 24, 2003.
28. Organización Mundial De La Salud (OMS): Necesidades de energía y de proteínas. Informe de una Reunión Consultiva Conjunta FAO/OMS/UNU de Expertos. Ginebra, 1985.
29. International Diabetes Federation (IDF): The International Federation of Diabetes consensus worldwide definition of the metabolic syndrome. 2005.
30. Rosen ED, Macdougald OA. Adipocyte differentiation from the inside out. Nat Rev 2006; 7: 885-96.
31. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847-53.
32. Kaippert VC, Rosado EL, Rosa G, Oliveira EMM, Uehara SK, D'Andrea CL, Nogueira J y Lago MF. Influencia de la grasa de la dieta en el metabolismo glucídico de mujeres obesas con el genotipo Pro12Pro en el gen PPARgama2. Nutr Hosp 2010; 25 (4): 622-9.
33. Lenhard JM, Gottschalk WK. Preclinical development in type 2 diabetes. Adv Drug Deliv Rev 2002; 54: 1199-212.
34. De la Torre ML, Bellido D, Soto A, Carreira J and Mijares AH. Standardisation of the Waist Circumference (WC) for each range of Body Mass Index (BMI) in adult outpatients attended to in Endocrinology and Nutrition Departments. Nutr Hosp 2010; 25 (2): 262-9.
35. Kohen VL, Candela CG, Fernandez CF, Rosa LZ, Milla SP, Urbieta M y Lopez LMB. Parametros hormonales e inflamatorios en un grupo de mujeres con sobrepeso/obesidad. Nutr Hosp 2011; 26 (4): 884-9.
36. Spurlock ME, Houseknecht KL, Portocarrero CP, Cornelius SG, Willis GM, Bidwell CA. Regulation of PPARg but not obese gene expression by dietary fat supplementation. J Nutr Biochem 2000; 11: 260-6.